Related Experiment Video
Updated: Jun 19, 2026
06:09
Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
Published on: September 30, 2017
Francisella tularensis vaccines
1Biomedical Sciences, Dstl Porton Down, Salisbury, Wiltshire, SP4 0JQ, UK. pcoyston@dstl.gov.uk
Vaccine
|October 20, 2009
Summary
Francisella tularensis poses a bioweapon threat, necessitating effective vaccines. Research is exploring the live vaccine strain (LVS) and alternative strategies to overcome challenges in vaccine development.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Francisella tularensis is a highly infectious bacterium with significant biothreat potential.
- Human disease caused by F. tularensis is severe, and no licensed vaccine is currently available.
- An attenuated live vaccine strain (LVS) has historical use but requires further understanding.
Purpose of the Study:
- To investigate the mechanisms of attenuation for the F. tularensis live vaccine strain (LVS).
- To elucidate the immune responses required for protection against F. tularensis.
- To explore alternative vaccine development strategies, including subunit vaccines and defined attenuated strains.
Main Methods:
- Analysis of LVS attenuation factors.
- Characterization of host immune responses to F. tularensis infection and vaccination.
- Development and evaluation of novel vaccine candidates.
Main Results:
- Ongoing efforts to understand LVS attenuation and protective immunity.
- Progress in developing alternative vaccine approaches.
- Identification of challenges in vaccine licensing due to animal model limitations.
Conclusions:
- Understanding LVS attenuation is crucial for developing improved vaccines.
- Novel vaccine strategies are being pursued to address the lack of licensed protection.
- Limitations in animal models present a hurdle for the successful licensing of new F. tularensis vaccines.
Related Concept Videos
01:51Vaccinations
Overview
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...